430 related articles for article (PubMed ID: 29279074)
1. Metabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT in Obese Patients.
Monteiro AM; Ferreira G; Duarte H
Acta Med Port; 2017 Nov; 30(11):813-817. PubMed ID: 29279074
[TBL] [Abstract][Full Text] [Related]
2. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging.
Christen T; Sheikine Y; Rocha VZ; Hurwitz S; Goldfine AB; Di Carli M; Libby P
JACC Cardiovasc Imaging; 2010 Aug; 3(8):843-51. PubMed ID: 20705265
[TBL] [Abstract][Full Text] [Related]
3. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects.
Oliveira AL; Azevedo DC; Bredella MA; Stanley TL; Torriani M
Obesity (Silver Spring); 2015 Feb; 23(2):286-9. PubMed ID: 25522219
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET/CT.
Tahara N; Yamagishi S; Kodama N; Tahara A; Honda A; Nitta Y; Igata S; Matsui T; Takeuchi M; Kaida H; Kurata S; Abe T; Fukumoto Y
J Clin Endocrinol Metab; 2015 May; 100(5):E739-47. PubMed ID: 25695885
[TBL] [Abstract][Full Text] [Related]
5. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
Rivers JP; Powell-Wiley TM; Dey AK; Rodante JA; Chung JH; Joshi AA; Natarajan B; Sajja AP; Chaturvedi A; Rana A; Harrington CL; Teague HL; Lockshin BN; Ahlman MA; Yao J; Playford MP; Gelfand JM; Mehta NN
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):349-357. PubMed ID: 29055628
[TBL] [Abstract][Full Text] [Related]
6. Visceral fat metabolic activity evaluated by
Pahk K; Kwon Y; Kim MK; Park S; Kim S
Obes Res Clin Pract; 2020; 14(4):339-344. PubMed ID: 32561167
[TBL] [Abstract][Full Text] [Related]
7. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue imaging the potential and the challenge.
Gropler RJ; Peterson LR
JACC Cardiovasc Imaging; 2010 Aug; 3(8):852-3. PubMed ID: 20705266
[No Abstract] [Full Text] [Related]
9. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
[TBL] [Abstract][Full Text] [Related]
10. Performance Evaluation of a Semi-automated Method for [
de Boer SA; Spoor DS; Slart RHJA; Mulder DJ; Reijrink M; Borra RJH; Kramer GM; Hoekstra OS; Boellaard R; Greuter MJ
Mol Imaging Biol; 2019 Feb; 21(1):159-167. PubMed ID: 29789994
[TBL] [Abstract][Full Text] [Related]
11. Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
Pahk K; Rhee S; Kim S; Choe JG
PLoS One; 2016; 11(2):e0148776. PubMed ID: 26862754
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
13. A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study.
Vanfleteren LE; van Meerendonk AM; Franssen FM; Wouters EF; Mottaghy FM; van Kroonenburgh MJ; Bucerius J
Respir Med; 2014 Jun; 108(6):883-90. PubMed ID: 24785152
[TBL] [Abstract][Full Text] [Related]
14. A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.
Torigian DA; Green-McKenzie J; Liu X; Shofer FS; Werner T; Smith CE; Strasser AA; Moghbel MC; Parekh AH; Choi G; Goncalves MD; Spaccarelli N; Gholami S; Kumar PS; Tong Y; Udupa JK; Mesaros C; Alavi A
Acad Radiol; 2017 Aug; 24(8):930-940. PubMed ID: 27769824
[TBL] [Abstract][Full Text] [Related]
15. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans.
Virtanen KA; Lönnroth P; Parkkola R; Peltoniemi P; Asola M; Viljanen T; Tolvanen T; Knuuti J; Rönnemaa T; Huupponen R; Nuutila P
J Clin Endocrinol Metab; 2002 Aug; 87(8):3902-10. PubMed ID: 12161530
[TBL] [Abstract][Full Text] [Related]
16. Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of
Liu J; Yang X; Yang J
Ann Nucl Med; 2021 Mar; 35(3):386-396. PubMed ID: 33469854
[TBL] [Abstract][Full Text] [Related]
17. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Shao D; Tian XW; Gao Q; Liang CH; Wang SX
Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinoma.
Van de Wiele C; Van Vlaenderen M; D'Hulst L; Delcourt A; Copin D; De Spiegeleer B; Maes A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):110-116. PubMed ID: 27730330
[TBL] [Abstract][Full Text] [Related]
19. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
20. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M
Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
